- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04103658
NIR and Skin Cancer Margins
Near-infrared Heating of Skin to Delineate Non-melanoma Skin Cancer Lesions: a Pilot Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Non-melanoma skin cancer (NMSC) is the most common cancer diagnosis in Canada, and its incidence is still increasing. Visual examination followed by biopsies of suspicious lesions are the gold standard for skin cancer diagnosis. The mainstays of treatment include photodynamic therapy, radiation therapy, and surgical excision. The margins of NMSC lesions are typically determined via visual inspection, and excised based on delineating normal from abnormal tissue. According to the National Comprehensive Cancer Network, low-risk basal cell cancers should be excised with a 4mm margin; squamous cell skin cancers and high-risk basal cell cancers should be excised with 4-6mm margins, as per the National Comprehensive Cancer Network. These lesions frequently occur on cosmetically sensitive areas of the head and neck, therefore accurate margins and excision can help to preserve the overall appearance. Accurate lesion delineation with proper margins can also reduce the need for further treatment if the margins are positive. In approximately 2-3% of cases at our centre, the margins are positive.
Near-infrared radiation (NIR) represents the light spectrum from 0.7 to 1.5 micrometers. At the shorter wavelengths, it merges with the red spectrum of visible light. These forms of light have the ability to heat the skin up to a 5 mm depth. Previous studies have examined the relationship between skin blood flow and temperature when heating skin, where dermal temperature can reach a certain peak in a defined time. Other studies have investigated the application of NIR when combined with photo immunotherapy, as a means of treating other cancers. More elaborate multispectral analysis devices have been studied for their effectiveness in diagnosing cutaneous malignancies. NIR application is well tolerated, in past studies.The objective of this study is to determine if the vasculature of normal skin and NMSC skin appears differently following heating with NIR light, and if this difference corresponds to better margin delineation.
The excisions and reconstructions are all within the standard of care. The only added testing will be application of near-infrared heat via a heating lamp to the lesional skin, for a total of ten minutes. Each patient will have their skin cancer lesion photographed, and traced onto acetate film. The NIR heating will then occur under a lamp for a total of ten minutes at a distance of 20cm. At the end of the ten minutes, the lesion and its borders will again be traced onto a separate acetate film. Using Excel for block randomization, patients will then be randomized to excision with the non-heated versus heated margins. The allocation will not be known until the moment of assignment. The excisions will then occur in the same fashion between the two groups, and all specimens will be submitted for pathology, as is standard of care.
Data will be recorded for various patient and lesions factors that may potentially influence the outcome of NIR heating therapy. These include age and gender, lesion size and location, and history of skin disorders. The lesion size and final pathology, with quantitative margin distances, will be recorded. Statistical analysis will be performed to determine if there is an overall difference in qualitative (negative or positive) and quantitative margin status between those lesions excised under standard procedure vs. NIR heating.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kiersten Pianosi, MD
- Phone Number: 18074 519-685-8500
- Email: kpianosi@uwo.ca
Study Contact Backup
- Name: Corey Moore, MD
- Phone Number: 66383 519-685-8500
- Email: corey.moore@sjhc.london.on.ca
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The patient population includes individuals with a nonmelanotic cervicofacial cutaneous malignancy referred to a tertiary care skin cancer clinic for definitive treatment. Patients must have:
- Histologically confirmed nonmelanotic cutaneous malignancies, either basal cell or squamous cell carcinoma
- No prior treatment with investigational agents
- Ability to tolerate intended treatment Patient's age is greater than or equal to 18 years
Exclusion Criteria:
- Prior radiation therapy or photodynamic therapy to the area with the NMSC lesion
- Patients with a history of cutaneous photosensitization
- Unable to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard of care (control)
This will be the standard of care group.
The excision of the non-melanoma skin cancer will be based on standard visual inspection with 4-6mm margins.
|
|
Experimental: NIR heating
This will be the NIR heating group, where the excision of the non-melanoma skin cancer will be based on the lesion margins based on the application of near-infrared radiation (with 4-6mm margins).
|
Same as the arm/group description.
The NIR heating group will have the non-melanoma skin cancer lesion excised based on the lesion borders established from application of NIR heat at a distance of 20cm for 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Margin status
Time Frame: 3 months
|
Difference in margin status between the control and the near-infrared heating group.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin vascularity changes
Time Frame: 3 months
|
Visual changes in the vasculature of normal skin and NMSC skin following application or NIR light.
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 114153
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-melanoma Skin Cancer
-
Skin Analytics LimitedInnovate UKCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingSkin Cancer, Non-MelanomaFrance
-
Technische Universität DresdenCompletedNon-melanoma Skin CancerGermany
-
Assiut UniversityCompleted
-
Skin Analytics LimitedInnovate UKCompleted
-
Xoft, Inc.Enrolling by invitationNon-melanoma Skin CancerUnited States
-
University of Colorado, DenverWithdrawn
-
University of Alabama at BirminghamCompleted
-
University of PennsylvaniaUniversity of Missouri-Columbia; Oregon Health and Science University; Stanford... and other collaboratorsCompletedSkin Cancer, Non-Melanoma | Mohs Micrographic Surgery | Skin Cancer MelanomaUnited States
-
University of Alabama at BirminghamActive, not recruiting
Clinical Trials on Near-infrared heating
-
Afeka, The Tel-Aviv Academic College of EngineeringHebrew University of JerusalemCompleted
-
Charles (Chuck) RaisonTerminatedMajor Depressive DisorderUnited States
-
University of MiamiOffice of Naval Research (ONR)Completed
-
China Medical University HospitalNot yet recruiting
-
Maastricht University Medical CenterActive, not recruitingDiabetes Mellitus, Type 2Netherlands
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Brooke Army Medical...CompletedHemorrhagic ShockUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownAnemic Preterms, Cerebral Oxygenation,Somatic Oxygenation,Blood TransfusionTurkey
-
Tel-Aviv Sourasky Medical CenterNot yet recruiting
-
National Cerebral and Cardiovascular CenterRecruiting
-
Chinese University of Hong KongNot yet recruitingTraumatic Brain Injury | Intracerebral HemorrhageHong Kong